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Phase 1: Background Research 
• Literary research
• Market Research
Phase 2: Field Research
• Online Survey
• Interviews
• Participatory Design Workshops
Phase 3: Design & Development
• Design Criteria




Phase 4: Usability Testing
• Remote user tests and test findings
• Discussion and moving forward
5-stage Project
Methodology This study examines the current technology of diabetes management devices, primarily insulin pumps. Insulin pumps are 
effective tools for the precise control of glucose levels, for type 1 
diabetes (T1D) patients. Many design and usability challenges still 
exist with insulin pump technologies. In this study, we investigated 
current shortcomings and limitations of insulin pumps through 
survey and interview data collection methods. Our findings 
revealed issues with current insulin pumps including: 
1) wear-ability and accessibility in public
2) operating devices while performing demanding tasks 
3) interruptions with social activities and interactions
4) continuity of maintenance, and 
5) interface operations. 
Using the data from our investigative work, we produced design 
criteria to develop a novel wrist-worn interface and separate
pump design for a closed loop artificial pancreas system. We then 
evaluated the design through seven remote usability testing
sessions with insulin pump users. Our study aspires to inform the 
future design of novel insulin pumps that enable people with
T1D to maintain better control of their glucose levels through 





A blood test that measures a person’s average blood sugar 
level over the past 2 to 3 months. A normal A1C level is 
5.7% or lower. People with diabetes may have an A1C of 
6.5 or higher. The goal for most people with diabetes is to 
have an A1C of 7% or less. 
Artificial Pancreas System 
(also known as a closed loop system)
A device network consisting of a continuous glucose mon-
itor and insulin pump. The continuous monitor tracks 
glucose levels and sends that data to the insulin pump, 
so the pump can automatically deliver the appropriate 
amount of insulin.
Autoimmune disease 
A disorder where the body’s immune system mistakenly 
attacks its healthy tissues. In the case of diabetes, the 
immune system attacks the pancreas’ beta cells which 
produce insulin.
Basal Insulin 
A small steady flow of insulin that is always present in the 
body, primarily while fasting between meals. In people 
without diabetes, this is known as basal secretion. People 
with diabetes must either inject a long-lasting insulin 
that replicates basal secretion, or program a basal rate 
using an insulin pump.
Blood Glucose Level 
(also referred to as blood sugar level) refers to how much 
glucose is in the bloodstream at a given time. This level is 
very important for people with diabetes, and they must 
monitor their blood glucose level throughout the day. If 
the blood glucose level is too high, there isn’t enough in-
sulin in the blood. If it’s too low, there’s too much insulin.
Blood Glucose Meter 
a small, portable device used by people with diabetes to 
check their blood sugar levels. After pricking the skin with 
a lancet, one places a drop of blood on a test strip in the 
meter. The device soon displays the blood sugar level as a 
number on the digital display.
Glossary of Common 
Diabetes Related Terms
Bolus Insulin 
After a meal, the pancreas releases the right amount of 
insulin to process the carbohydrates in the meal. This is 
known as bolus secretion. People with diabetes must cal-
culate a dosage of insulin based to the grams of carbohy-
drate in the meal, known as a bolus.
Continuous Glucose Monitor
A small wearable device, usually worn on the abdomen, 
with a sensor that penetrates the skin. This device is able 
to take glucose readings every few minutes, throughout 
the day. The continuous glucose monitor also utilizes a 
transmitter, which sends glucose readings to a separate 
monitor or smartphone app.
Correction Bolus
A bolus that is taken in order to correct a high blood 
glucose level.
Carbohydrates 
one of the three main nutrients in food. Foods that pro-
vide carbohydrate are starches, vegetables, fruits, dairy 
products and sugars.
Carbohydrate Counting 
a method of meal planning for people with diabetes, 
based on counting the number of grams of carbohydrate 
in food.
Diabetes Mellitus 
a condition characterized by hyperglycemia resulting 
from the body’s inability to use blood sugar for energy. In 
Type 1 diabetes, the pancreas no longer makes insulin and 
therefore blood sugar cannot enter the cells to be used for 
energy. In Type 2 diabetes, either the pancreas does not 
make enough insulin, or the body is unable to use insulin 
correctly.
Diabetic Ketoacidosis (Ketosis)
An emergency condition in which extremely high blood 
glucose levels, along with a severe lack of insulin, result 
in the breakdown of body fat for energy and an accumu-
lation of ketones in the blood and urine. Signs of ketosis 
include nausea, vomiting, stomach pain, fruity breath 
odor, and rapid breathing. Untreated ketosis can lead to 
coma and death.
Insulin 
a hormone that helps the body use glucose for energy. The 
beta cells of the pancreas make insulin. When the body 
cannot make enough insulin, it is taken by injection or 
through use of an insulin pump.
Insulin Pump
an insulin-delivering device about the size of a deck of 
cards that can be worn on a belt or kept in a pocket. An 
insulin pump connects to narrow, flexible plastic tubing 
that ends with a needle inserted just under the skin. Users 
set the pump to give a steady trickle or basal amount of 
insulin continuously throughout the day. Pumps release 
bolus doses of insulin (several units at a time) at meals 
and at times when blood sugar is too high, based on pro-
gramming done by the user.
Meal Bolus
An insulin bolus taken before a meal.
Neuropathy
disease of the nervous system. The three major forms in 
people with diabetes are peripheral neuropathy, auto-
nomic neuropathy, and mononeuropathy. The most com-
mon form is peripheral neuropathy, which affects mainly 
the legs and feet.
Retinopathy
An eye disease that is caused by damage to the small 
blood vessels in the retina. Loss of vision may result. (Also 
known as diabetic retinopathy)
Target Range
Blood glucose levels need to stay within a certain range, 
and when you have diabetes, you must regulate your 
blood glucose levels with diet, exercise, and (perhaps) 
insulin. Before meals, the target range is 70 to 130mg/
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Insulin pump technology has advanced rapidly over the 
last decade. Major pump makers are introducing the first 
Food and Drug Administration (FDA) approved closed 
loop architecture, matching the pump with a Continuous 
Glucose Monitor (CGM), where the devices communicate 
via Bluetooth. This device network simulates the 
characteristics of a pancreas to regulate glucose levels 
more accurately. The Dexcom mobile application allows 
users of their proprietary CGM to track and share real-
time glucose data with, designated family members and 
healthcare providers [1].
Pump interfaces have begun to diverge from the 
more traditional mechanical buttons and display.  
Touchscreens are being implemented in some newer 
designs, either integrated on the pump itself, or 
accompanying as a wireless controller. While touch 
screen interfaces are becoming more popular in insulin 
pump design, they still pose some limitations to users 
as they rely heavily on ‘eyes-on’ interactions. Haptic 
features (e.g. mechanical buttons) can play an important 
role in operating insulin pumps by facilitating eyes free 
interactions [2], but their value may be underestimated.
Additionally, people with impaired vision may have 
trouble using touch screens and must use other methods 
for managing diabetes.  For example, some have elected 
to use V-Go which was designed for people with Type 2 
diabetes.  Since the device’s interface consists of three 
buttons, and doesn’t make use of a digital display, it 
can be operated without any visual cues. However, it 
has limitations: basal rates cannot be changed, and 
the device can only deliver one 2-unit bolus at a time. 
People with T1D often need much more precise dosage 
increments to properly manage glucose.
Other researchers have conducted studies on the 
design and human factors aspects of insulin pumps. For 
Introduction And Related Work 
on Insulin Pumps
example, Tandem Diabetes researchers referred to their 
process as “prevention through design” and worked with 
end-users to test user perceptions and viability of the 
pump’s interface, to determine what information should 
be present on various screens and calculate health risks 
that may occur during specific interactions with the pump 
[3]. While companies like Tandem are making strides to 
ensure their products are safe and easy to use, there is 
still a need for further research and development on the 
usability of insulin pumps. 
Due to the nature of challenges and the lack of concrete 
solutions, hacking into the system software of insulin 
pumps became increasingly popular in the diabetes 
community. For example, Dana Lewis [4] started modifying 
her pump and CGM, to make her alarms louder in case she 
experienced dangerously low glucose levels at night. This 
led to developing a simple algorithm that could forecast 
glucose levels and make dosage corrections. This work 
has been shared with the open-source community, which 
initiated #OpenAPS (Open Artificial Pancreas System) [5]. 
Lewis and Leibrand [6] later explored Open APS systems 
effectiveness and participants reported reduced average 
glucose levels, spent approximately 40% more time within 
target glucose range, and all but one improved sleep [7]. 
Other open source systems such as the Loop mobile app 
(designed for automated insulin delivery) have been 
developed by DIYers in the diabetes community to control 
older insulin pumps, via a Raspberry Pi based device 
(RileyLink), which translates the wireless signals of the 
pump, CGM, and smartphone; allowing the devices to 
communicate [8]. The DIY community coalesced further 
by introducing hashtag #WeAreNotWaiting to denote 
the need for more rapid technological development, 
increased interoperability of devices, and better data 
exchange. DIYers continue to use the hashtag, expressing 
their intention to overcome regulations and the limited 
proprietary technologies currently available [7].
How it works
RileyLink was developed, to allow a Bluetooth 
connection between a smartphone and a 
compatible insulin pump. Using the Tidepool 
Loop app, DIYers can control their pump via 
smartphone. Furthermore, the system can 
monitor glucose and automatically deliver 
insulin, without user intervention.
Open Source and the FDA
While these open source advancements have 
enabled people with T1D to take better control 
of their diabetes, the FDA has not approved any 
of these technologies. More specifically, the 
FDA has not approved of any systems where a 
cellular-enabled smartphone can control an 
insulin pump. 
1. CGM sends Glucose  
     Levels to RileyLink. 
2. RileyLink translates
      and sends glucose data     
      to the phone.
3. Phone App calculates 
      insulin dosage, based 
      on glucose data.
4. RileyLink takes bolus 
      calculations from the 
      phone, and tells pump to 




The RileyLink / Tidepool 
Loop Ecosystem
Fig 1, Graph showing the “closed-loop“ 








      Medtronic 670G
The most popular new 
model on the market. 
The 670G is also the first 
FDA approved Closed-
loop system that comes 
with a proprietary CGM 
which requires twice daily 
calibrations.
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      Smart Insulin Pens
Several companies have 
produced smart insulin 
pens, which carry a several 
day’s supply of short acting 
insulin. The smart pens 
are able to connect to 
smart phone apps which 
aggregate data like insulin 
on board, and blood 
glucose logs.
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      EverSense CGM
EverSense utilizes a 
microchip, implanted 
under the skin. The oval-
shaped sensor can be taped 
or even waved over the chip 
location, to obtain glucose 
readings.
3
      Dexcom CGM
The Dexcom G6 can 
communicate glucose 
data to a dedicated 
PDA, smartphone, 
or smartwatch.  This 
device does not require 
calibrations, which often 
involve periods of fasting 
and checking glucose via 
traditional glucose meters.
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      Insulet Omnipod
The first tubeless insulin 
pump design; Omnipod is 
controlled via a dedicated 
PDM with integrated 
glucose meter, or cellular 
disabled Samsung 
smartphone. This pump is 
also compatible with the 







      V-Go
V-Go does not run on 
batteries.  The pump is 
worn like a patch, similar to 
Omnipod. It was designed 
for T2D, however, it has 
been adopted by some 
T1D patients who suffer 
visual impairment, such as  
diabetic retinopathy.
6
      Tandem T:Slim X2
The touchscreen 
Interface is the pump’s 
unique feature. The pump 
advertises a compact 
design, and is compatible 
with Dexcom’s CGM to 
create a closed loop system.
7
      RileyLink
Part of the DIY movement: 
RileyLink is typically a 
raspberry pi computer, 
programed to link with 
compatible CGM’s and older 
insulin pumps. This creates 
one of the first open APS 
closed loop systems.
8
      Loop App
An open source app: 
Tidepool’s Loop App 
enables users of the 
RileyLink to control 
compatible insulin pumps 
using a smartphone. The 
app takes the patient’s 
carb ratios, insulin 
sensitivity, and correction 




      Legacy Pumps
Some older Medtronic 
pumps are being 
adopted by DIYers. Used 
in conjunction with 
RileyLink, Loop App, 
and a CGM, these pumps 
have become part of a 




      Glucose Meter
The traditional approach 
to monitoring blood 
glucose. Meters require 
a blood sample. Newer 
meters can transmit 
glucose data to insulin 
pumps via Bluetooth. 
They are also required for 
calibrating some CGM’s, 
like the Medtronic.
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The current state of 
diabetes technology
Current market research helped to reveal 
possible design opportunities.  While 
touchscreens are trending with devices like the 
Dexcom G6 receiver and T:slim X2, legacy pump 
designs with mechanical buttons are phasing 
out. 
Several products exposed challenges that 
specific groups of people face. The V-Go pump 
(image 6) is designed for people with type 
2 diabetes, however, it has seen some use 
from type 1 diabetics who suffer from vision 
impairment. “The V-Go is great for those who 
are blind but has its limitations... Exact dosing 
is limited compared to insulin pump therapy. 
Most people with type 1 diabetes require a basal 
other than what it provides…” [9].  The Tidepool 
loop App combined with RileyLink device also 
revealed the increasing demand for capable 
closed-loop systems.
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People tend to wear insulin pumps in areas of the 
body that have low flexion and movement, such 
as thighs and upper arms (see figure 4). Wearing 
locations also tend to have a larger surface area, 
such as the abdomen and buttocks.  One reason 
these areas are chosen has to do with the location 
of the injection site. The abdomen and upper arm 
are considered ideal injection locations because 
these locations are able to absorb insulin more 
quickly. All of these areas are thought to have 
adequate fatty sub cutaneous tissues, which 
reduces the chance of injecting directly into 
muscle tissue and causing pain and irritation [10].
These common pump wearing sites are also 
considered ideal dynamic wearable zones (see 
figure 2) for electronic wearable devices. The 
low flexion and high surface area of the upper 
arm, abdomen, buttocks, and thighs make them 
ideal areas that help wearable devices to feel 
unobtrusive [11].  Something else that Gemperle, 
Et Al. Pointed out is that wearable devices may be 
considered less obtrusive and more comfortable 
to wear if they feature a concavity on the surface 
touching the body (see figure 3). This is thought 
to better fit the convex curvature of the human 
anatomy. Virtually all current insulin pumps 
feature a single point of attachment, such as a 
clip, and have a square form which may feel more 
separate from the body, thus more obtrusive.
Pump Wearing Locations Correlating with 
Gemperle’s Ideal Dynamic Wearable Zones:
• Abdomen






Fig 5, Ideal insulin pump infusion sites, recommended by Medtronic Diabetes
Fig 2, Visual Depiction of Gemperle’s Dynamic Wearing Zones Fig 4, Locations Mentioned by Interviewees
Fig 3,  Gemperle’s illustration, showing the process of 
transforming a block to a humanistic wearable form: 
A) Concave against the body, B) Convex on the outsice surfaces, 
C) Tapering, as the form extends off the body, D) softening edges 








A 12-question survey was dispersed 
to several online forums, through 
JDRF, and personal contacts, which 
garnered 105 responses. 68 of the 
respondents were female, 35 were 
male, and 2 did not disclose gender. 
Average age range of respondents was 
45-54. 
The goals of the survey were to 
collect a representative sample that 
could show how people interact with 
pumps, common pain points, and 
most desired new features they would 
like to see in an insulin pump. The 
end of the survey featured two open-
ended questions, asking participants 
to express their deeper opinions 
about current technology. Participant 
names were coded (R1 – R105) to 
protect identities.
A portion of the survey focused on 
interacting with pumps eyes-free 
vs. eyes-on. The survey data showed 
that 30% of respondents use their 
pumps without looking at the screen.  
Roughly 12% of all respondents 
admitted to having difficulty reading 
the display on their pump interfaces. 
Finally, 50% of the survey respondents revealed 
that they wish pumps could convey more 
information without having to look at the 
screens.
The survey mentioned four specific design 
features, and asked respondents to rate which 
features would be most important to have 
in a new insulin pump. Features included a 
small wireless controller, sends voice alerts to 
earbuds or hearing aids, better haptic/vibration 
feedback alerts, and sending current detailed 
information to a family member. Some of these 
features do currently exist. Several pump and 
CGM models come with a proprietary PDA-like 
device (e.g. Omnipod ). Several mobile apps 
are also capable of sharing glucose levels with 
others. Haptic feedback was hypothesized to 
be a potential interaction method for people 
with vision impairment, as well as a universal 
feature for those who feel the need to operate 
pumps without having to look at a screen. 
Small wireless controllers came out as the 
most desired feature, followed by sending 
current information to a family member, and 
better haptic feedback. The chart to the right 
depicts responses to the question, “What design 
features would be most important for you to 













































MOST DESIRED NEW DESIGN 
FEATURES FOR AN INSULIN PUMP
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“The new pump is very hard 
to turn on (wake up). I know 
this is to prevent accidentally 
(bolusing), but as I get older 
and my hands are weaker, it 
has become an issue. Also, if I 
touch the wrong part of the 
screen it goes to sleep.”
“In a movie theatre, the
 pump displayed an audible 
alarm for urgent low BG. That 
was as expected and I was 
sure to respond, but I knew 
the pump would alarm and 
again, until the glucose 
ingested increased BG levels.”
“Since Omnipod is 2 separate 
pieces, the PDM is often not 
in the room I’m in. I left it at 
home the other day and the 
pod started beeping while I 
was in a store.”
         “The pump is in a 
vertical case and requires 
a tilting upward motion to 
read data”
          “Trying to unhook a 
hinged pump clip from my 
bra to bolus before dinner at 
a restaurant. These new 
pump clips are so difficult.”
     “My pump is also my
CGM receiver. When I’m 
driving and get an alert, or 
just want to look at my 
numbers, it can be difficult - 
awkward - to finagle it out of 
my pocket.”
“I had to wear a formal dress 
to a wedding. No good place 
to put it.”
“This pump is heavy and 
bulky. Wasn’t designed well 
for women.”
“Caught tubing on door handle 
and pulled insert out. Happens 
frequently.”
“I had to wear a formal dress 
to a wedding. No good place 
to put it.”
“It beeped during a 
meditation class and I was 
asked to leave it in the car, 
next time.”
“Any time I go out to lunch or 
dinner, on business, or with 
friends.”
    “It always runs out of 
insulin at the worst time at a 
meeting because I try to use 
all my insulin and extend the 
pump supplies.”
“As a professor, it can be 
awkward to stop in the middle 
of lecture to deal with a pump 
alarm. Otherwise, I generally 
don’t worry about pulling my 
pump out in front
 of others”
-R##
“Clearing any alerts 
while skiing or wearing 
thick gloves”
The end of the survey featured 
two open-ended questions, asking 
participants to express their deeper 
opinions about current technology.  
Answers were then organized 
into affinity diagrams for further 
analyzing. infographics in figures 
(XX) graphically show how each of the 
answers were categorized.
When asked to describe a situation 
where using a pump was awkward 
or difficult, several major themes 
Survey:
Awkward Situations
emerged:  accessing the device 
interface from the person’s wearing 
location, affecting social activities, 
feedback and alerts, and wear-ability. 
The answers revealed particular 
wearing challenges for women. 
For example, R-87 stated, “I have 
quit wearing dresses and skirts 
since it is difficult to get to my pump 
without having to find a bathroom.  I 
have even gone off the pump for 24 
hours so I could function easily at 
my son’s wedding” 17 respondents 
specifically mentioned challenges 
they face regarding insulin pumps 
and women’s clothing.
Even where pumps don’t directly 
affect social occasions, the affinity 
diagrams revealed that pumps often 
interrupt various activities. “I often 
get alarms when driving.  This by far 
is the most inconvenient time as I 
want to respond and, if necessary, 
administer a bolus.  This is often 
very awkward.” (R 35) Trying to 
safely access a pump while driving 
was mentioned 7 times. Seventeen 
respondents mentioned situations 
where pump maintenance inhibits 
another task, such as exercising, 
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comments







































“A remote ‘insulin 
suspend’ device a 
companion could 
use in case of 
emergency; one of 
these switches 
worked with my 
three MiniMed 
pumps.”
  “Vibrating, not   
 alarm, for attention  
      requirement.”
“A one-touch 
'silence' button on 
the top of the pump 
for audio alarms at 
inconvenient times.  
Let it automatically 
become vibrate 
every 10 minutes 
to remind.”
“All alerts 
could be vibration 
only when needed, 
or the ability to 
completely suspend 
alerts for an hour 
or so.”
     “ability to create 
shortcuts to most 
often performed 
actions.”
  “Not go through 
so many steps to do 
a simple bolus!”
“Smaller, fewer 
presses to get to the 
right screen / 
process”
     “since you asked, 




 “More aggressive  
      auto-mode or  
“closed loop” mode.”
“Make it tubeless! 
I love everything 
about my tandem 
pump but the 
tubing can be 
inconvenient at 
times.”
“The loop BG 
settings need to be 
completely 
adjustable per each 
persons unique 
chemistry.”
“I would like it to 
function as a 
pancreas with 
accuracy. I know it 
will come soon.”
    “better CGM.      
 Better connectivity  
  with non Apple   
       products.”
   “Being able to 
control my pump 
with an app on my 
cell phone.  Very 
important.”
  “I’d like to see, &
  be able to control    
  it from my phone.”
“ability to see and 
deal with pump 
from phone and 
watch. I do not want 
an additional item 
to carry. watch / 
phone / pump are 
plenty of devices”
 “Bluetooth Voice    
  activation control.”
        “remote so that 
I don't have to take 
it off and on to do 
something.”
“Better wireless 
remote - easy to use 
without looking 
at it.”   “If all pump 
brands can sync 
with all cgm brands.  
I have to use my 
smartphone to scan 
the sensor and 
manually input the 




CGM display.  
Connectivity with 
the iWatch is 
alright, but is lost 
way too often.  This 
forces the removal 
of the pump and 
replacement.”
“Integrated CGM 
(all in one 
pump / cgm)”
 shift between 
profiles for 
exercise.  I do not 
have Control-IQ 
(soon to be 
released) but I wish 
such systems would 
have customizable 
target levels.”
“I wish the PDM 
was rechargeable, I 
hate having to use 
so many batteries.”
“Clips do not allow 
enough rotation for 
easy viewing 
(without breaking).  
They are not 
durable (I get that I 
want the clip to 
fracture before the 
pump). ”
     “I would make it 
much much smaller, 
and something that 
sticks on the skin 
unlike wearing it on 
belt clips, thus 
giving us women 
more access to what 
we desire to wear.”
“I would like it to 
look less ‘medical’ 




Respondents answered the question:
“If you could have any new feature in 
an insulin pump, what would it be?”
The majority of respondents 
expressed desires to control their 
pumps from a smartphone app.
Other areas included redesigning 
the form of the pump, streamlining 
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Interviews were conducted after completion of 
the survey, to collect more in-depth data around 
participants issues with insulin pumps. Seven 
participants were recruited through a JDRF Facebook 
group and through contacts at JDRF corporate offices in 
Atlanta. 
Participants included 5 females and 2 males. The 
average age range of all participants was 34-44. All 
interviewees use pumps and CGM’s. Two of the female 
participants also use the Tidepool open source system. 
One tidepool user also suffers vision loss due to diabetic 
retinopathy. Participant names were coded (P1 – P7) to 
protect their identities. 
The interview format started with introductory 
questions focused on pump model, wearing location, 
and inquiring about other 3rd party apps or products 
each person might use. The main section consisted 
of situational questions that related to using insulin 
pumps for routine activities, like taking a meal bolus. 
Final questions focused on using pumps in situations 
where it might be difficult to do so. 
Many participants discussed issues with pump 
interfaces, during the situational questions. For P7, 
the bolus history section was a pain point. “One of my 
biggest complaints on this pump is the recall history. 
Bolus/Basal history is a very poorly organized section 
of the interface. Hard to tell boluses apart. No logical 
spreadsheet breakdowns.” Figure 6 shows P7’s bolus 
history screen. Some pump history sections don’t 
feature clear breaks between each bolus given. In P7’s 
example, all previous boluses appear to merge together. 
This may be considered a false cognitive affordance [12].
Because social situations were revealed as a strong pain 
point in the survey comments, interview participants 
were also asked to recount any socially awkward 
Interviews
1. What make/model pump do you use?
2. Where do you typically wear your pump?
3. Do you use any 3rd party mobile applications with your pump/to manage diabetes?
4. Do you ever find it difficult to access your pump from where you wear it?
5. Can you walk me through giving a bolus?
6. Do you take any extra measures for when your pump is low on insulin?
7. What might you do if you get an alert or need to use your pump while driving?
8. Do you ever find your self in situations where it might be socially awkward to use 
your pump? What have you done in those situations
9. Invitation for Questions and Thoughts
Interview Questions:
situations relating to their insulin pumps. Several 
participants mentioned experiences where their pumps 
became a public distraction. P5 discussed one Interaction 
in an academic setting. “I had a professor who had a 
really stringent rule as far as phones. ‘If I hear your 
phone, you gotta’ buy donuts for the whole class…’ One 
day, I ran out of insulin in class. Of course, it started 
beeping like a madman. Long story short, it made noise 
and the professor said, ‘We’ve got our first phone. I guess 
you’re buying donuts for the whole class!’”. Regarding 
alerts, P7 expressed a desire for more customizable alert 
settings for different pump functions. “It would be good to 
have different customizable things for different features…
Every time I’m low or high, I don’t want it beeping as loud 
as I want it beeping if I have an occlusion.”
Many survey respondents mentioned needing to use 
pumps while driving. Interview participants were also 
asked about using pumps while driving, which revealed 
further insight on these pain points. On the subject of 
getting pump alerts while driving, P4 stated: “I know the 
functions and I’m a safe driver in general. But I would just 
pull it out and try to take care of it at the next stoplight.” 
P1 mentioned pump interaction without taking her eyes 
off the road: “I’ve memorized functions. I bolus while 
driving...Like if it says I’m high, and it’s alerting me, I will 
lie about eating carbs just to get the bolus.” P7 discussed 
using a trusted passenger’s help, while driving: “A lot of 
the time, if I’m on a road trip, my girlfriend might be 
sitting in the passenger seat. And I’ll hand her the pump 
and be like, ‘can you give me 5 units?’” P5 also stated: “If 
I have someone else in the vehicle, like my brother for 
example. If he’s in the passenger seat, I’ll just say, ‘hey, 
here’s my pump.’” 
Fig 6, Pump interface showing the bolus history section.
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Interviewees often discussed the number of devices they 
must carry around on a daily basis. P2 may carry as many 
as 7 devices with her, mainly when traveling for work. Those 
devices include insulin pump, RileyLink transmitter, Dexcom 
CGM receiver, CGM wearable, smartphone using the tidepool 
loop app,  glucose meter, and a spare syringe and insulin 
bottle which is kept in a cooler.  Even when people with T1D 
aren’t forced to carry a large assortment of gadgets, these 




Figure 8 illustrates areas where each of the interview 
participants wear insulin pumps and related devices. 
Where applicable, the graph also details stories 
or scenarios related to wearing pumps, CGM’s and 









If I’ve got jeans on, I’ll just 
cary it [RileyLink receiver and 
smartphone] in my pocket. If I 
don’t, I’ll stick it in a purse
or bag...
- Participant 6
Always in my pocket.
- Participant 7
I put it on a belt clip. When I
first went on a pump, the biggest 
issue I think I had was (tubing) 
getting caught on door knobs.
- Participant 5 
I usually wear it in my bra, just to have less stuff 
hanging off of me. Sometimes in my pocket, like 
today I have it in my pocket. Just because I don’t 
want to reach into my shirt to grab it.
 - Participant 4
I’m wearing it in my arm right now, 
and I bump into doorways. I never 
really thought, “ ok I’m gonna hit 
something.” You never notice it, until 
you have a device attached to you.
- Participant 3
I usually keep it on my waistband. 
If I have a pocket, I will consider 
putting it in my pocket. I don’t put it 
on my bra, lik a lot of other women. 
I don’t like to access it from there!
 - Participant 1
Pump on wasteband. CGM attached 
to me. I keep the RileyLink, Dexcom
PDA, and Smartphone in my purse.
 - Participant 2
My wedding day was difficult. 
Trying to figure out, “where can 
I even stick stuff ?” I don’t want 
it in pictures. Where can I put my 
devices so that they’ll be hidden 
and still work?
- Participant 3
Obviously, I’m wearing my Dexcom 
on my forearm. I’m usually very overt 
about the fact that I’m diabetic. I’m 
like, “ask me about it! Ask me what 
that weird band aid is on my arm.” 
 - Participant 6
Figure 3, Photographs of interview participants’ pumps and devices.




   “I’ve had issues 
with it. I was just at 
my endochrenologist 
on Monday, and I’ve 
got a prescription 
now for insulin pins 
with treciva and 
novolog. I’m thinking 
of switching to that 
for a time. Just to give 
myself a break from 
the pump.”
  -P7
     “I started 11 years 
ago on a CGM, and it 
was the first 
Medtronic one. After 
about a year, I took a 
year off.”
  -P1
“I don’t know what 
it’s like to live 
without half my brain 
going to this stuff. 
Like, I really don’t.”
  -P1         “I know that 
even if my pump 
says I don’t have any 
insulin on board, I 
still have 15-20 
units, because of the 
infusion set. So, if 
I’m not going too far 
outside of the 
general home range, 
I probably won’t do 
anything about it 
until I get home.”
  -P4
“I always bring a 
backup with me, 
because I’ve had 
them leak before or 
just straight up fail. 
They start beeping 
and it’s aweful…I’ve 
always got extra 
insulin and a 
syringe in my bag.”
  -P6
 “I will say, the 
quick bolus on the 
animas ping is 10 
times easier than the 
quick bolus on this. 
That’s an older 
design, and I used to 
use that all the time.”
P7
   “(Eating at 
restaurants) I don’t 
bolus until I have 
food in front of me. 
I’m way too paranoid 
that it’s not gonna 
come out in time. Or 
I’m thinking this is 
gonna be 5 cups of 
food, and it’s really 
only 2 and ½ cups. Or 
visa versa.”
-P3
  “Whatever 
algorithm is baked 
in, it takes into 
account things like 
my insulin sensitivity 
factor that I set, my 
carb ratios, the 
insulin curve based 
on the type that I’m 
using, and my 
glucose and how 
that’s changing.”
  -P6
There have been 
times where I’ve had    
 to pull over. Because  
 I’m struggling to get  
it to work or because  
  it has an occlusion  
    alarm, and then 
I’ve got to respond




      “If I have   
someone else in the 
vehicle, like my 
brother for example. 
If he’s in the 
passenger seat, I’ll 
just say, “Hey, here’s 
my pump. Dial up a 
bolus of XX amount.” 
and he’ll just shoot 
the insulin.”
  -P5
 Oh, I’ve 
memorized the 
functions. I bolus 
while driving. I will 
generally. Like if it 
says I’m high, and it’s 
alerting me...
  -P1
“I totally do while 
I’m driving. Which is 
really dangerous! The 
nice thing is that the 
(Loop) App does have 
face recognition. If I 
put in the carbs and 
hit deliver, and just 
stick my face in front 
of it, it’ll go.”
  -P6
 “I was in the 
middle of a quiz. It 
was silent. Nothing 
going on, and I felt it 
going out of insulin 
and I was like, “It’s at 
my side”. (it would 
look like using a 
cheat sheet if he 
peaks down) So finally, 
I reached down… 
switched it (the 
insulin cartridge) 
out and left it on the 
table. That way, if the 
professor was curious, 
he could see.”
  -P5
     For a formal 
situation, before this 
pump and CGM, I 
would probably just 
disconnect and do 
injections… But now 
that the CGM is 
attached with it, I 
feel better keeping it 
all connected. 




“My wedding day was 
difficult. Trying to 
figure out, where can 
I even stick stuff. I 
don’t’ want it in 
pictures. Where can I 
put my devices so 
that they’ll be 
hidden and still 
work... I had to give 
my sister my bag and 
be like, ‘I need you to 
guard this with your 
life, and if anything 
happens, interrupt 
what’s going on and 
help me.’”
  -P6
        “Particularly for 
younger children, the 
app allows parents to 
see it as well. For that 
matter, I gave it to my 
doctor.  And he could 
track my blood sugar 
whenever he wanted. 
Apparently, there 
were times where he 
would call someone’s 
parents and be like, 
‘hey are you worried 
your kid’s having a 
low?’ I didn’t have the 
tech for it. I really 
didn’t want to buy an 
apple phone just for 
that.”
  -P5
Using the Dexcom, 
I’m constantly 
checking. But losing 
the riley link the 
other day, I started to 
work myself into a 
panic. Because I was 
like, ‘I’m gonna have 
to go back to my 
receiver, and this 
whole thing isn’t 
going to work until I 
find it. What if it’s 
giving me too high of 
a basal rate right 
now? And it’s stuck 
on that, because I lost 
the thing.’ It’s anxiety 
inducing for sure!”
  -P6
One of my biggest 
complaints on this 
pump is the recall 
history. Bolus/Basal 
history is a very 
poorly organized 
section of the 
interface. Hard to tell 




“I wish that 
they (alarms) were 
more customizable 
for various things. 
It would be good 
to have different 
customizable sounds 
for different 
features… Every time 
I’m low or high, I 
don’t want it beeping 
as loud as I want it 
beeping if I have an 
occlusion.”
  -P7
“in general, it just 
gives me too many 
alerts. Even during 
the day. If you’re not 
just steady on target 
all the time (which I 
would love to be) it 
can’t keep me there.”
  -P1
Inconveniences
           “I’m wearing it 
on my arm right now, 
and I bump into 
doorways. I never 
really thought, “ok I’m 
gonna hit something.” 
I was reading so much 
about people with 
young kids. The tube 
just made me nervous.  
I feel like I’m gonna 
knock that out, and I 
didn’t like the idea of 




“Using the Dexcom, 
I’m constantly 
checking. But losing 
the riley link the other 
day, I started to work 
myself into a panic. 
Because I was like, 
“I’m gonna have to go 
back to my receiver, 
and this whole thing 
isn’t going to work 
until I find it. What if 
it’s giving me too high 
of a basal rate right 
now? And it’s stuck on 
that, because I lost the 
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units, because of the 
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I’m not going too far 
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until I get home.”
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-P3
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algorithm is baked 
in, it takes into 
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my insulin sensitivity 
factor that I set, my 
carb ratios, the 
insulin curve based 
on the type that I’m 
using, and my 
glucose and how 
that’s changing.”
  -P6
There have been 
times where I’ve had    
 to pull over. Because  
 I’m struggling to get  
it to work or because  
  it has an occlusion  
    alarm, and then 
I’ve got to respond
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don’t want it beeping 
as loud as I want it 
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Note: All quoted Rileylink 
users are female
Interview participants shared 
meaningful personal stories about 
living with diabetes and using pumps. 
These stories reinforced the survey 
findings and helped point to multiple 
design opportunities. Participants 
had the most to say about using 
pumps while performing demanding 
activities, like driving. Using pumps 
in public or social situations was 
another strong discussion topic.
Similar to the open-ended survey 
data, participant quotes were 
arranged in an affinity diagram, 
then distilled into the diagram.
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User Journey maps
User experience maps helped to highlight the 
specific difficulties people experience with 
insulin pumps, in their daily lives. These user 
experience maps were designed, based on quotes 
from the survey and user interviews. The maps 
focus on several common types of activities that 
participants mentioned frequently.
Each experience map is divided into four 
quadrants. The prompt is a given task someone 
would perform on their insulin pump, in order to 
perform a given activity. The response shows how 
the insulin pump acts during that activity. The 
last quadrant shows the reactions of users and 
the general public.
Wear-ability and alerts are two pain points that 
emerged from the exercise user journey.  
Prompt Response Reaction Result
• Sets a temporary basal 
rate.
• Disconnects pump.
• Proceeds without extra 
action.
• Adjusts pump wearing 
location.
• Audible Low glucose 
alert.
• Temporary rate alert.
Exercising is difficult 
because you have to 
flip the pump out of 
the way when you do 
floor exercises.
-Respondent 68, Female
Clearing any alerts 
while skiing or wearing 
thick gloves. 
-Respondent 66, Male
Just yesterday while riding 
my bike in traffic, I could 
hear a persistent pump alert 
and I was reluctant to look 
to see what it was and there 
wasn’t a safe place to stop 
and check.  I would have liked 
the comfort of a message 
sent to hearing aid - a non-
critical alert, “only 15 units 
remaining in cartridge.” 
-Respondent 29, Male
• Attempts to silent pump 
alarm.
• Feelings of being 
inconvenienced.
• Feelings of insecurity.
• Undesirable public 
responses.
I was in an exercise class and 
the alarm went off.
-Respondent 82, Female
It beeped during a 
meditation class and I 
was asked to leave it in 
the car next time.
-Respondent 36, Female
• Continues exercising, 
with a clear picture of 
physical condition and 
pump’s state of activity.
• Rests momentarily, to 
snack and allow glucose 
to correct.
• Must stop exercising 
completely, to address 
blood sugar.








The two common threads among people performing activities 
were that they are either distracted by devices, or the device is 




Whether participants use their pumps while driving or 
not, all contributors expressed views that using a pump 
while driving is not advisable and potentially dangerous.
Prompt Response Reaction Result
• Needs to check blood 
glucose/CGM status.
• Needs a meal bolus.
• Needs a correction 
bolus for high BG.
• Needs to correct low 
blood glucose.
• Persistent alerts won’t 
stop until dealt with.
• Glances CGM data on 
smartwatch.
• Checks CGM on pump or 
smartphone.
• Feelings of being 
inconvenienced.
• Feelings of insecurity.
• Distraction.
• Attempts to silence 
pump alarms.
• Pump hasn’t alarmed for 
an urgency.
• Audible high blood 
glucose alert.
• Audible low blood 
glucose alert.
• Low battery or insulin 
alert.
There have been times 
where I’ve had to 
pull over because I’m 
struggling to get it to 
work, or because it has 
an occlusion alarm, and 
then I’ve got to respond 
to that. And I’ve got to 
resume insulin delivery.
-Participant 7, Male
I totally do while I’m 
driving, which is really 
dangerous! The nice thing 
is that the loop app does 
have face recognition…
If I put in the carbs and 
hit deliver, and just stick 
my face in front of it, it’ll 
bolus.
-Participant 6, Female
• Continues driving having 
quickly checked CGM 
data.
• Temporarily distracted 
while interacting with 
pump and driving.




My girlfriend might be 
sitting in the passenger 
seat, and I’ll hand her 
the pump and be like, 
“can you give me 5 units?”
-Participant 7, Male
I would just pull it out 
and try to take care of 




Formal occasions are another scenario where pumps and CGM’s can 
draw unwanted attention. The formal occasion journey map also 
highlighted wear-ability problems for women.
Prompt Response Reaction Result
• Continues without 
drawing attention.
• Pauses to address 
pump/health issues 
with the public’s 
knowledge
• Misses out on the 
occasion, to address 
diabetes/pump issues.
• Programming a meal 
bolus.
• Checking blood glucose.
• Removing the pump.
• Selecting different 
clothes.
• Audible low blood 
glucose alert.
• Low battery or insulin 
alert.
• Pump not immediately 
available.
I have even gone off 
the pump for 24 hours 
so I could function 
easily at my son’s 
wedding. 
-Respondent 87, Female
The battery needed 
changing during a work 
meeting and it alarmed 
every 5 minutes. I 
couldn’t turn it off 
because it was under 
my clothes so I had to 
excuse myself.   
-Respondent 28, Female
• Feelings of being 
inconvenienced.
• Feelings of insecurity
• Distraction.
• Attempts to silence 
pump alarms.
•  Excusing ones’ self to 
tend to health/pump 
issues.
As a professor, it can be 
awkward to stop in the 
middle of lecture to deal 
with a pump alarm. 
Otherwise, I generally 
don’t worry about 
pulling my pump out in 
front of others.    
-Respondent 53, MaleHad to wear a formal 
dress to a wedding. No 
good place to put it.
-Respondent 91, Female













The goal of conducting workshops was to gain better 
understanding of how people use pumps during regular 
activities, and find solutions that meet people’s needs by 
having actual users design their own concepts for 
insulin pumps.
Three one-on-one workshops were held with Georgia Tech 
students. Each person came from various colleges of the 
institute, including psychology, computer engineering, and 
computer science. Participant names were coded (P1 – P3) to 
protect their identities. 
The workshops consisted of 4 activities—Introductory questions, 
mind map session, collage activity, and a design session. Each 




Each participant was asked to list the following 
items, in order to start thinking about possible 
design solutions:
• What devices to you use to manage your 
blood glucose? List them.
• What are 2 or 3 of your favorite activities?
• What are some activities you do on a 
regular basis? (Give examples like driving, 
getting ready for a night out, going to class, 
meetings)
• What could your devices do better when 
you are performing these activities?
• What new features would you like to         
see in a new insulin pump?
Collage Activity
The activity helped people to get 
comfortable with thinking creatively. The 
final collage also helps to inform the study 
as a rough mood-board for the final design.
Design Session
Participants used sketching tools 
and Playdoh to articulate design 
solutions that they formulated 
from the previous activities. 
Introductions
To start each workshop, participants 
were asked questions about their 
story with T1D, insulin pumps they 
currently use, and area of study.
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“An ideal pump for me, would be 
something like an Omni, where it’s 
tubeless. But, I would want it to look 
like the Eversense. So like, the size of 
the eversense is ideal for me. Maybe 
a little bigger. Even the structure of 
it. More circular. Flat. I think that 
just looks better on the body too than 
what the Dexcom looks like right now. 
...For me, having a smaller, flat, more 
ergonomically friendly pump site 





“It’s gotta be sticky like 
duct tape. It would be nice 
if we didn’t have to use 
skin tack beforehand.”
How cool would it be if it was just the 
    Insulin pump and the CGM, together!
Participant 1 expressed desires for an all-in-
one solution, where the pump and CGM are 
integrated. This would reduce the number of 
devices one must wear, to manage diabetes.
Form was also important. P1 referenced a 
streamlined CGM design that resembles a 
pebble or smooth river rock. According to P1, 
doing this would make it easier for people to 








Figure 9, photograph of the collage from PD workshop 1
photographs taken from PD workshop 1
“I think circular is better 
than the weird shapes we’ve 
got going on, now.  I wouldn’t 
mind refilling it every 
day, if  it was smaller.”
38 39
“Being able to be compatible with 
devices that we use every day. I’m 
always on my phone. I feel like 
the technology is there. We could 
probably just get something that 
could work with your phone. Just 
the ability to do some things on your 






        “It is a device that
        I have to wear. 
      Maybe it could 
have other qualities. 
A device that 
can do more things 
than just give insulin.”
“Everyone says 
  my pump 
is like a robot.”
Participant 2 developed a circular shaped 
model, that could be used as a patch-style pump 
or a traditional tubed pump. 
During the collage activity, P1 expressed several 
key ideas. 
• A pump that saves money by using fewer 
materials
• A design that does more than just deliver 
insulin and monitor glucose, like a Swiss 
army knife or multi-tool
• Integrated data sharing features that 
would make it easier to communicate with 
one’s endocrinologist on a regular basis
• An aesthetically pleasing and comfortable 
form.
Workshop 2 Results:
photographs taken from PD workshop 2
Figure 10, photograph of the collage from PD workshop 2
40 41
“It should definitely be something 
that’s small and out of the way. I 
was talking to my doctor and he was 
like, “you’re going to latch your wire 
onto a door”, and I was like, “I don’t 
want that to happen!”. So, it should 
definitely be something that’s out of 
the way.
For me, that interconnection has 
been the best. When I can see my 






I want to be able to go out in nature, 
not be connected to the internet, and 
still be able to function properly.
It should be there when 
           you want it to be there. 
               Other than that, you should 
              feel like it’s not.
“Why not have the pump also be a CGM? If I already have 
two, just stick it in one. I figured it could be some sort of 
replaceable type pod, where you could just put it in.”
Showing the Pump/Pod inserted into the 
yellow CGM cradle.
The Pump/Pod can be removed from the cradle for 
convenient refilling. 
Participant 3 also designed an all in one Pump/
CGM. It was also important for the design to 
be compact. The design shows the amount of 
insulin in the cartridge at all times. 
Other design directions that came out of this 
workshop included making sure the pump 
enables people to be active, by consolidating 
the pump and CGM into one device. This would 
reduce the number of devices to pack before 
leaving for a trip, or for work.
Integrating dieting tools was another key issue 
for P3. He felt that integrating a database of 
nutritional and carbohydrate information into 
the pump interface could reduce the stresses of 
memorizing carbohydrates in food. 
Workshop 3 Results:
Slot for inserting traditional 
glucose test strips
Figure 11, photograph of the collage from PD workshop 3





Benchmarking, Iterative Sketching, 




• Remote Control Device
• Consideration for keeping track 
of how much insulin is left in the 
pump cartridge. (Not running 
out of insulin at bad times)
• Enables better wear-ability and 
clothing options for women
Interactive Features
• Better haptic/vibration feedback
• Streamlined navigation (i.e. 
fewer clicks to perform certain 
functions)
• Enables interaction with minimal 





• Wear-ability options; especially 
when attending formal occasions 
like weddings.
• Keeping track of insulin left in 
pump cartridge.
• Reducing the number of devices 
one must carry around.
Interactive Features
• Enables interaction with minimal 
affect on social activities
• An organized bolus history 
that allows the user to better 
understand how much active 
insulin is in the body.
• Enables better interactions while 
performing demanding activities 
like driving, or job interviews.
Participatory Criteria
Pump Design
• All-In-One pump CGM Design 
Option to wear as a “patch“ 
pump or traditional pump
• Compact size
• Rounded edges for more 
comfortable wear-ability
• Reduce the number of devices 
one must carry around
Interactive Features
• Smartphone integration
• Account for hacking 
vulnerability
• Multi-functional
Before creative development could 
begin, design criteria needed to be 
formed. Criteria was drawn from 
initial research findings, survey 
and interview insights, and the 
participatory design workshops. 
The design criteria was developed 
to guide the creative process to an 
adequate solution. 
Any new design for an insulin pump 
must also pass FDA inspection in 
order to be released to the public. For 
this reason, FDA guidelines were also 
Other Considerations
FDA Regulation
The FDA has not approved any smartphone 
apps which could control an external insulin 
pump, wirelessly.  Such Mobile Medical Apps 
could pose a risk to patient safety if they don’t 
function as intended [13].
Final Design Criteria
Pump Design
• Remote Control Device
• Enables better wear-ability and clothing options, 
especially for women
• Reduce the number of devices one must carry around.
• Intentionally designed as a dedicated medical device.
Interactive Features
• Better haptic/vibration feedback
• Enables interactions while performing demanding 
activities like driving, or job interviews.
• Enables interaction with minimal affect on social 
activities
• Smartphone integration
considered so that the final design 
might meet the legal and safety 
standards of other FDA approved 
medical devices.
Once the strongest insights and 
guidelines were extracted from 
each stage of research, they were 
organized into a more concise set of 
guidelines which became the final 
design criteria. These insights were 
often things that reappeared in 
multiple stages of research.
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Several artifacts were benchmarked, in order to gain 
insight on the sizing and function of crucial internal 
components, and common features found in pump 
interfaces. This  helped to establish specific standards 
for designing an insulin pump and interface system. 
Benchmarking also helped to reveal design flaws in 
some of the current devices and interfaces that were 
examined.
Once benchmarking research was done, each closed-loop 
system was evaluated in a product usability matrix, to 
help determine where the design opportunities are for a 











 Main Cradle: 
 Houses infusion set     
 and muscle wire for    
 pumping insulin
 PCB with integrated antenna
 Chassis with Peizo buzzer
The patch-style Omnipod was chosen as an analog for tear-down. The pump’s body 
measures 51mm long, 38mm wide, and 14 mm tall. While most pumps use a stepper motor 
for pumping insulin, the Omnipod uses a ratcheting system, powered by muscle wire. The 
muscle wire  hardens and shortens in length when given an electrical charge, driving 
the gear system to rotate and pump insulin in precise increments [14]. The reservoir also 





To help provide further reference for internal 
components and practical dimensions of an 
insulin pump, a 3ML insulin cartridge and 





 Infusion Set  Transmitter
The CGM infusion set injects a small conductive 
wire under the skin. The transmitter attaches 
to the infusion set, using small snap fit hooks 
and gasket rings on the inlet port. The adhesive 




Snap fit hooks 
& inlet port
Insulin Pump Motors
Illustration of a Faulhaber stepper motor 
inside an insulin pump.





Micro-motors are commonly used in insulin 
pumps for precise delivery. The micro-motor 
maker, Faulhaber, advertises products which 
are intended for use in insulin pumps. Below 
are examples of several motors.














Examining user interfaces of 
the most widely used pumps 
and CGM devices helped to 
form a benchmark for what 
needs to be incorporated 
in a closed loop system 
interface. The elements 
found in nearly all of these 
UI include the following:
• CGM glucose levels
• Active insulin in body
• Insulin in the pump
• Current time
• A trend graph
Trend arrow shows 
glucose trajectories. 
Current Glucose
Active amount of 










Share feature shares glucose data 




Tidepool loop is the only 
mobile app that can be 
used to control an insulin 
pump. Since the FDA has 
not approved apps for the 
purposes of controlling 
pumps, people with T1D 
must use this open-source 
technology at their own risk.
Loop is a very comprehensive 
app, accounting for extra 
factors like exercise 
patterns, and food fat 
content in order to deliver 
more precise increments of 
insulin over time.
Photographs taken from: 
https://www.youtube.com/watch?v=V5Tqh6b51zU
CGM Data displays as a 
complication on the watch face.
Touching the complication 
opens the app.
Tap “Bolus“ to initiate 
a correction bolus.
Use the + or - icons 
(or rotate the watch 






Use the + or - icons 
(or rotate the watch 
crown) to adjust units 
of insulin.
Selecting different 
food icons will deliver 
insulin over extended 
time periods, according 
to food’s absorption 
rate.
Press “Bolus“ button.
Tap “Carbs“ to initiate 
a meal bolus.
Triangles indicate when a 
bolus has been programed 
by the user.
Glucose Trends graph: the 
dotted line indicates past 
levels. The dashed line (- - -) 
indicates predicted future 
glucose levels.
Indicates amount of 
insulin in the pump. 








Bolusing user flows are nearly 
identical between smartphone and 
watch. The smartphone flow does 
take an extra step, by requiring finger 
print or facial scan authentication 
before delivering a bolus.





The dexcom app works with 
the company’s continuous 
glucose monitors, to 
display blood glucose data. 
The app displays one 
screen, showing glucose 
data. Users cannot use the 
app to perform functions.
The Dexcom watch app utilizes one 
screen, showing a trends graph as 
well as the user’s current glucose. 
The arrow icons next to the glucose 
number indicate glucose trajectory 
(whether blood glucose is going up or 
down). 
CGM data from the dexcom app can 
also be displayed as a complication 
on several main watch face layouts 
of the apple watch. This allows users 
to check CGM data without needing 
to drill further into the apple watch’s 
menus.
CGM Data Shown as a Complication on the Watch Face
Dexcom Apple 
Watch AppDexcom Apple Watch Layout
Face layout options displaying 
a small complication.
Face layout options displaying 
a prominent complication.
Trend arrow shows 
glucose trajectories. 





Share feature shares glucose data 
with up to 10 followers
Glucose remaining steady (not increasing/
decreasing rapidly)
Could increase/decrease between 30-60 mg/dl 
in 30 minutes.
Could increase/decrease between 60-90 mg/dl 
in 30 minutes







The Omnipod Dash system uses a 
cellular-disabled Samsung Galaxy 
as the controller. This is the 
only system that uses a wireless 
controller as the primary means to 
control the insulin pump.
This system does have a few 
limitations. It does not integrate 
with a CGM device. While the 
wireless controller is an actual 
smartphone, the device doesn’t 
allow users to download apps.
The application has a few usability 
issues. There isn’t a uniform 
process for number entry. In the 
bolus section, the user types the 
number of carbs, but uses a slider 
to enter a blood glucose number. 
The bolus section also jumps to  a 
separate page to allow the user to 
enter a glucose number.
Omnipod Dash 
Bolus User Flow
The controller uses a lock 
screen that resembles most 
smartphone lock screens. 
Users can set the device to 
require a pass code.
The first screen that 
appears after unlocking 
the device is the Omnipod 
home screen.
Lock Screen Home Screen
The most dominant 
element displays 
insulin on board 
(active units of 
insulin in the body)





1). Tapping the bolus 
button brings the device to 
the bolus section.
2).  Tapping the “carbs“ text 
box allows carbohydrates 
to be typed in.
3).  Tap the dashes (     ) 
in the BG section to enter 
blood glucose, manually.
4).  A new screen appears 
for entering blood glucose.
5). The calculator jumps 
back to the bolus screen 
after a glucose has been 
entered. 
Tap “CONFIRM“ to go to the 
next screen.
6). Review the confirmation 
screen before starting a 
bolus.
7).  A bolus progress screen 
appears, after the bolus has 
been started.
8).  The interface returns to 





Five common Pump/CGM systems were assessed for wear-ability and interaction. Systems 
with fewer required devices score higher for wear-ability, since there’s less to carry. Systems 
with multiple available interface options scored a higher interactivity rating. Devices that 
offer discreet operation include smartphones and smart watches, which do not resemble 
medical devices. Tubeless design scored higher for wear-ability, since participants and survey 
respondents frequently commented on tubing catching on objects. Wireless control helps with 

































































(Dummy smartphone not available 

















Ideal interaction. Poor wear-abilityPoor wear-ability. Poor interaction.
Ideal interaction and wear-abilityIdeal wear-ability. Poor interaction.
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Sketching allowed for fast iterative idea generation, 
based on  the design criteria. The processes for sketching 
the physical pump, controller, and digital interface were 
very similar. At the beginning of the process, a myriad 
of rough sketches were produced. Over several internal 
reviews with my committee, those ideas were narrowed 
down until a final cohesive concept was formed.
Iterative Sketching
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Several forms were considered for 
a new controller. It was important 
that the device fit the form of objects 
that people carry on a daily basis. 
Smartphones, wallets, keys, jewelry, 
multi-tools, and pens often fit that 
description. After several sketches, 
the concept for a wrist-watch 
controller quickly emerged as an 
ideal form, due to the familiarity 
and benefits of a smartwatch-style 
controller.
Key Benefits
• Ideal body placement for haptic 
feedback
• Discreet interaction
• No need for cellular capabilities 
(unlike smartphones and mobile 







Leaf Tilt the leaf face to scroll
Press the button to select / 
advance screens





droplet Droplet: tilt the face to scroll content.
Pen
Safety cap covers buttons 
when not in use.








Circle Exposed (exposed side is used for swiping / scrolling content)
Circle Exposed: Front View Circle Exposed: Back View
Square Face. Hump Buttons.Round Face. Hump Buttons Round Face. Side View Breathable Band
Rams Concept
The watch controller went through 
several concept sketches before 
settling on a final design. Goals 
for determining a form were to 
incorporate a non-touch screen 
interface, which may facilitate 
effective “eyes-free“ interaction. The 
form and visual style of the controller 
also needed to pair with the pump 
design as part of a product family.
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The patch style pump was chosen 
as the form to fulfill design criteria. 
Patch style pumps tend to offer more 
flexible clothing options for women, 
since they are placed directly on 
the body, and not in a pocket, belt-
clip, or carrying case. As survey and 
interview participants mentioned, 
patch pumps don’t have any tubing 
to catch on objects. Lastly, all of the 
pump designs from the participatory 




Refillable Patch Pump Concept:
Miniature pump design:
For use while exercising, or as an emergency backup.
Curved Plinth Shape: 
Intended to fit around the curvature of the 
body/wearing locations.
• Form design may also work for a controller
Worn on the wrist 
as a controller
Sketched with an arm band
Unclips from infusion site
Soft, rubberized infusion site:











The circle concept was chosen for the watch 
controller. The controller features a capacitive 
touch senor pad, for swiping through screens. 
There are two buttons; one selection button 
and one back button.  The detail sketches also 




PCB with Haptic Motor
and transmitter antenna
Wireless Recharging Coil
Option 1: Modern Band
Wrist View
Option 2: Band integrated into case:
Button View







Pump and CGM Holster
Pump and CGM Holster: Top View






(injection mold requires sliding shutoff)
Snap-fit Hooks
CGM Connection Pads 
Insulin outlet port
Pump body slides onto CGM Holster and fas-
tens to snap-fit hooks. Side View
Pump Body: Internal Parts
Outlet Port
CGM Holster
The final patch-style pump design consists 
of a holster which houses the infusion set for 
insulin delivery and CGM sub-cutaneous probe. 
The Pump Body slides onto the holster and is 
fastened into place with snap-fit hooks.
Two main differentiators of this concept are 
that the holster/body design allows the user to 
refill the pump without changing pump sites 
on the body. The second is the curved profile, 
which is meant to fit more closely to the body.
Parting line
Pump Body: Side View






Lower Half of Pump Body:
Keyholes fit over 
slide-fit tabs






All UI Sketching was done 
within a 1.4” circle, so that 
accurate scale is taken into 
account.
Each home screen sketch 
shows 2 -3 pieces of 
information at a time; 
Current time, a graphic 
representation of CGM 
glucose readings, and the 




Only showing glucose Only showing glucose Analog clock graphic.
Glucose shown as 106.
Showing time and 
battery. Divider line moves up and 
down, with glucose reading
Showing time, glucose (82),
and units in pump (185 u.)
The line on the right moves up and down according to blood sugar levels. At a normal level (i.e. 101), the line is 





Border lines on the left 
could display additional 
information. In this case, 
insulin left in the pump 
241
The line indicator and number 
move up or down. The two 
markers on left and right 
indicate ideal target level.
161
Combines elements of the 
border line, and adds a 
small circular indicator.
Circular Theme
A dial indicator or arrow 
on the circle could show 
glucose trajectory.
Background animations 
or color changes could 
indicate different states; 
• Delivering insulin






Layout option on the circular theme. 
no functional differences.
The display shows time and date on the large circle. The small circular indicator to the 





Other than the home screen, 
the bolus section tends to 
be the most commonly used 
section of a pump interface. 
Users need to calculate a 
bolus before virtually every 
meal. 
The storyboard explores 
a possible user flow for 
programming a bolus of 
insulin, before a meal.
Quick Bolus Feature
Check Blood Sugar History
Swipe up to 
access menu.
1. Home screen 2. Navigation Menu
Swipe






Automatically goes back 
to home screen, showing 
delivery progress.
Bolus User Path Sketch
UI shows a message that the pump 
is suspended. The large circle is 
highlighted, to show an alert state. 
Quick Access 
Features
Easy access features are 
common for insulin pump 
interfaces. Most pumps 
have a Quick Bolus feature, 
which gives users a simple 
option for correction and 
meal boluses.
 Suspending insulin 
delivery and checking 
glucose history are 
commonly performed tasks, 
which may also be useful in 
a quick access feature.
Suspend Insulin Delivery
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Many survey comments expressed a desire for a more 
efficient user flow. Statements like, “Not go through 
so many steps to do a simple bolus!” (R970), and 
“more user friendly” (R60), point to deficiencies with 
pump interactive design. Interview data also revealed 
shortcomings in the interface design.  As P7 stated, 
“Bolus/Basal history is a very poorly organized section 
of the interface. Hard to tell boluses apart. No logical 
spreadsheet breakdowns.”  With navigation being one of 
the more heavily discussed topics in the survey open-
ended questions and in the interviews, it behooved the 
study to take a ground-up approach to the interface 
design.
The interface design strategy was developed in tandem 
with UI sketches. The design strategy guidelines ensure 
consistency in the usability of the pump UI. This set of 
basic principles is meant to inform how much content is 
available to the user at any given time, general user flow, 
and visual style.
A design ecosystem was also developed in order to 
show where the controller and pump fit into the larger 








Convenience and intent represent the ideal combination 
of ease-of-use and safe use. Processes for regular actions, 
like bolus, should utilize few steps to complete. In other 
words, convenient. On the other hand, safeguards are 
necessary for preventing accidents. This means the 
user would only give a correction bolus when he or she 
intends to do so. The physical interface does not use a 
touch screen as one safe guard. The user must swipe the 
scrolling pad to activate the menu, then press the select 
button to select menu items. This safeguard is meant 
to reduce the likelihood of an accidental button push 
causing an unintentional interaction.
Good Good Not Good
Dominant, Sub-dominant, and 
Subordinate. Dominant and Sub-dominant.
Many elements. 
No clear dominance.Swipe the scrolling pad to activate 
navigation.
Pressing the select button opens up 
a new screen from the menu.




The wrist controller interface was designed to be glanced 
at on a regular basis, helping the user to have a clear 
picture of the state of his or her blood glucose. Since the 
interface is meant for glancing, information should be 
uncluttered and easy to interpret. Interactions should 
be kept simple. The amount of information present on 
the screen should also be limited. The dominant, sub-
dominant, subordinate design principle is a helpful 
guideline for the number of elements present on the UI, 




The watch face screen displays a complication for the Continuous Glucose Monitor. The CGM complication 
provides a snapshot for the user’s blood sugar at the present time. The primary information provided is 
actual glucose and trajectory.
CGM As A Watch Complication
Alerts appear as an overlay with alert message. Pressing the back button takes the UI back to the watch face, containing 
an alert icon. The alert also appears as the”in-focus” navigation  item, when navigation is prompted.
Critical Alerts
The navigation menu appears as a scrollable list. The 
menu item at the center of the display can be selected, 
leading to the next screen. Main menu items should be 
accompanied with graphic icons. Secondary menu items 
should only contain text.
Menu Navigation
The counter is used for tasks like programming a meal bolus, or manually entering a glucose level in instances when 
the CGM data is unavailable. 
Counter
Glucose Trajectory Arrow
Glucose remaining steady (not 
increasing/decreasing rapidly)
Could increase/decrease between 
30-60 mg/dl in 30 minutes.
Could increase/decrease between 
60-90 mg/dl in 30 minutes
Could increase/decrease more 
than 90 mg/dl in 30 minutes
Glucose is 112 (on target) 
and on a steady trajectory. 
Glucose is 255 (above 
target) and increasing at 
60-90 mg/dl per 1/2 hour.
Glucose is 73 (below target) 
and decreasing at 30-60 
mg/dl per 1/2 hour.
Glucose is 54 (severely 
below target) and 
decreasing at more than 
90 mg/dl per 1/2 hour.
Swipe up to increase carb 
count from zero.
Swipe down to decrease 
carb count.
Showing low battery alert. Face screen showing 
alert icon.
Alert shows up as 





The visual elements of the controller interface 
are kept simple in order to ensure that the 
UI is as glanceable as possible.  Each element 
serves one primary function, and is designed to 
provide quick interaction.
Non critical alerts represent state-changes with the system, such as temporary basal rate, delivering insulin, or 
delivery suspended by the user. Non critical alerts appear as a color animation of the dominant circular complication 
in the watch face home screen.
Non Critical Alerts
Default state of the watch 
face
Watch face showing a 
non-critical alert
Main menu Secondary menu
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The app sends data to 
healthcare professionals.
Healthcare professionals send messages 
and insulin ratios to the app.
The app sends CGM data and alerts 
to designated relatives and friends.
Contacts send alert confirmation 
responses and messages through the app. 
The smartphone app stores insulin
dosage basal settings, bolus ratios, 
and aggregates CGM blood sugar 
data for  healthcare providers and 
users to review.
The controller operates 
the pump. 
The pump sends current 
CGM data to the controller. 
The pump sends CGM data to the 





The diagram below illustrates how the new insulin 
pump-CGM Wrist controller system communicates. 
The wrist controller operates the main functions of 
the pump (bolusing, suspending the pump, temporary 
insulin rates, monitoring  current CGM data) The 
smartphone app,  delves deeper into the operation 
of the system without directly controlling the pump. 
While the controller is primarily pump facing. The App 
is primarily external facing. The app’s purpose is to 
visualize blood sugar and insulin dosage trends over 








2 in 1 
Pump and CGM
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CAD renderings were designed, based on final sketches. 
Where possible, CAD files of actual components were 
added to each model, in order to account for internal 
components.  The digital prototype was developed in 
order to test the final design. 































The pump and controller were 
designed as a product family. 
The visual language of the white 
enclosures with dark accents, 
help tie the two artifacts together. 
While the rounded designs are 
meant to enhance wear-ability, so 
the devices are less likely to catch 
on objects, the forms also help the 
pump and controller to match. 
Insulin Pump
Exploded View
It was crucial to consider internal 
components, for a functional pump 
design. The exploded view includes 
sourcable parts such as the stepper 
motor from Faulhaber, which is 
designed for medical devices. Other 
parts, such as the peizo speaker, 
LED light, and recharging coil, 





The curved form of the pump 
was influenced by participant 
design P1’s concept, based on the 
form of a river rock. This form 
was also strongly influenced by 
Gemperle’s design criteria for 
a humanistic wearable form. 
(figure 12) The concave base was 




The unique interface feature for the 
wrist controller, is the capacitive 
trackpad, intended for simple 
swiping interactions.  While a 
myriad of planar trackpads and 
touch surfaces exist, from laptops 
to touch screens, technology for a 
biconvex touch surface is in its early 
stages if not speculative. Several 
companies are developing in-mold 
electronic (IME) input devices [15, 
16]. In-mold capacitive technology 
involves thermoforming a flexible 
sheet containing capacitive ink 
onto a three-dimensional plastic 
part, creating a complex form that 
functions as a tactile touch interface. 
The current intended applications 
for IME devices include appliances, 
automotive interiors, aerospace 
industry, and consumer electronics. 
While IME may be a potential solution 
for the trackpad, considerations need 
Figure 13, Left: image of In-Mold-Electronics design[15] Right: Soft potentiometer being used for swipe interaction [18].
Fig 12,  Gomperdelle’s illustration 
of the humanistic wearable form.
Profile of the controller trackpad.
Side view, showing the pump’s concave base.
to be made to ensure the domed 
design could endure thermoforming 
without encountering drafting and 
warping issues. 
Attempting to prototype the 
controller utilizing IME would be 
out of scope for this study, however, 
the swiping interaction is testable 
by using several off-the-shelf 
components.  Interactions could 
be tested on the watch controller 
by placing a flexible 12.5mm soft 
potentiometer [17] on a physical 
model. These inexpensive sensors 
have been used for various swiping 
interactions [18] for basic physical 
computing applications.










The following pump 
renderings were used 
during user tests. These 
images communicate the 
general size of the pump, 
and it’s differentiating 
features: the curved 







Detailed renderings of 
the watch controller 
were also designed for 
the purposes of user 
testing. The renderings 
are meant to help inform 
users on functionality of 





Swiping the trackpad activates  
the main menu, from the main 
screen.
Swipe on the track pad for 
scrolling through menus, 
and adding or subtracting 
numbered items. 
Located on the lower part of the 
controller. Press the selection 
button, to make selections.
Press the back button 
go back one step. 
The back button is 





After rough wireframes were sketched, 
Protopie was used for designing the 
digital prototype, to be implemented 
for user testing.
The prototype features user paths for 
three commonly used interactions; 
programming a bolus, suspending 
delivery, and programming a 
temporary basal rate. Several quick 
access features were also designed for 
the prototype, including CGM detail 
view, quick suspend, and quick bolus.
Swipe the trackpad to bring up the 
main navigation.
Landing page of the suspend feature.
The interface returns to the home 
screen, showing a non-critical 
suspend alert. 
Swiping the trackpad brings up the 
menu, now showing “resume“ in place 
of “suspend“







The diagram to the right shows 
the wireframe for suspending 
basal delivery. Suspend is a crucial 
feature, found in all of the example 
interfaces. A person with T1D may 
suspend a pump to prevent a 




The following diagram shows 
the wireframe for programming 
a bolus. A pump user needs to 
program a bolus before each meal. 
The diagram also shows the basic 
user path for canceling a bolus in 
progress. This can be useful if the 
bolus calculation was wrong, or if 
meal time is delayed.
The controller’s static home screen 
shows time, blood glucose number, 
and the glucose indicator arrow.
Landing page of the bolus section Swiping up on the trackpad adds 
carbs to the carb counter element
Press the select button to see the 
bolus calculation
Landing page shows the amount of 
insulin being delivered
Swiping the trackpad brings up the 
main navigation menu.
If the select button is pressed again, 
the interface lands on the home 
screen, showing insulin delivering.
Press the select button again, to 
confirm the amount of insulin for 
a bolus
Once the bolus completes 
delivering, the interface 
returns to the home screen.
Press the back button while the pump is delivering, to cancel a bolus in progress. 
Once the bolus is canceled the pump jumps back to the home screen.
Canceling a bolus in progress
1.
2.





Temporary rates are typically 
executed in preparation for 
exercise. In this wireframe, a 
duration is set, then the basal rate 
can be adjusted by a percentage. 
The controller’s static home screen 
shows time, blood glucose number, 
and the glucose indicator arrow.
Landing page of the bolus sectionSwiping up on the trackpad adds 
carbs to the carb counter element
Press the select button to see the 
bolus calculation
Swiping the trackpad brings up the 
main navigation menu.
If the select button is pressed again, 
the interface lands on the home 
screen, showing insulin delivering.
Once the bolus completes 
delivering, the interface 
returns to the home screen.
Swiping up on the trackpad adds 
carbs to the carb counter element
Swiping up on the trackpad adds 
carbs to the carb counter element
1.
2.3.





The CGM graph quick feature is 
designed to give the user a detailed 
history of glucose levels over the 
previous several hours. 
From the home screen, press and 
hold on the select button.
The interface displays a graph 
showing Glucose trends over the past 
several hours.
Press the back button to return to 
the home screen.
Swiping the trackpad allows the 
user to examine each reading 





Quick features were incorporated as 
a possible means of reducing  eyes-on 
interaction. The quick features incorporate 
fewer button presses to accomplish 
tasks, and rely on the tactile feel of the 
mechanical buttons. Accessing a quick 
feature requires pressing and holding on 
the select button, back button, or both at 
the same time. 
Another, more obvious, goal of 
incorporating quick features was to 
enable users to accomplish tasks more 
quickly. Faster interface task completions 
could reduce the number and severity of 
interruptions people experience while 
doing regular activities, such as attending 




Quick bolus is another feature 
found on many pumps. This is 
useful when the user can’t give 
their undivided attention to 
calculating a fully accurate meal 
bolus. This feature allows the user 
to calculate in 1 unit increments. 
A process that should involve less 
mental strain than the standard 
bolus operation.
From the home screen, press and 
hold on the select and back buttons.
The interface jumps to the quick 
bolus landing screen, preset with one 
unit of insulin.
In the confirmation screen, press 
the select button to confirm dosageSwiping the trackpad allows the 
user to add units of insulin, for a 
bolus. Press the select button once 
the desired amount is reached.
Quick Feature:
Suspend Delivery
Suspend delivery is also 
incorporated as a quick feature. 
This may be an important feature  
to use in an emergency situation.
In this user flow, the pump would 
suspend in three steps. The 
standard interaction takes one 
extra step.
From the home screen, press 
and hold on the back button.
The interface jumps to the 
Suspend prompt screen.
The interface jumps to the 
Resume prompt screen.
The interface returns to the home screen, 
showing a suspend alert. Press and hold the 
back button again, to resume delivery.
Pressing the select button 
takes the interface back to 
the home screen. Normal 
delivery resumes.
The interface jumps to the 
delivery progress screen.
3
Once the bolus completes 
delivering, the interface 











Evaluating CAD Renderings, 
Testing the Interactive Prototype
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Stage 1: Cad 
Renderings
The below CAD renderings of the 
pump design were presented, which 
show several defining features.  These 
features include the curve, designed 
to hug the body and lifestyle images 
(to the right) to show the scale 
and intended wearing locations. 
Storyboards showing the refilling 
process were then presented. 
Renderings of the watch controller 
were also reviewed, showing the button 
layout and lifestyle images of the watch 
being worn on the left or right hand.
Testing 
Methodology
Before it was time for creative 
development and usability tests, 
the Covid-19 pandemic broke 
out, preventing access to Ga Tech 
campus fabrication recourses and 
in-person meetings. This meant 
shifting from in-person tests with 
physical models to web-based video 
conferencing sessions. During the 
remote sessions, participants were 
shown CAD renderings over screen 
share, then interacted with a web-
based interface prototype using 
their smartphones. A “think aloud” 
approach was applied for usability 
sessions, where participants were 
asked to talk through what they saw 
and interacted with [19].  This helped 
to establish a reliable communication 
line between tester and participant.
The goal of user testing was to 
evaluate acceptance and perceived 
usefulness of the pump/controller 
design, as well as usability of the 
controller interface. The one-on-
one remote sessions followed a 
three-stage structure. During stage 
one, participants reviewed the CAD 
renderings of the patch pump design 
concept and remote controller. 
During Stage two, participants 
completed four tasks using the 
interface prototype. In stage three, 
participants were invited to express 
any additional thoughts they had on 
the design concept. Each usability 
session took between 40-105 minutes 
to complete.
Seven participants were recruited for 
usability testing, through a Georgia 
JDRF Facebook support group, and 
various personal contacts. One of the 
participants acts as a caretaker who 
operates their 6-y/o child’s insulin 
pump. All participants reside in 
various counties throughout the state 
of Georgia. They include six females 
and one male. Average age was 35-44. 
Occupations included event planner, 
executive management, teacher, 













Participant evaluations of the 
pump’s curve, designed for optimal 
wear-ability, revealed valuable 
insights. The chart below maps 
responses in a Likert scale. Those 
who gave the curve positive reviews, 
supposed it would help prevent 
the pump from being knocked off. 
P3 mentioned, “My sensor sites 
have come off during workouts 
where I’m bending and twisting, 
or picking up kids. I think that it 
could potentially allow for it to not 
be constantly popping off, maybe.” 
P2 also discussed his daughter 
being prone to bumping into 
doorways, knocking her patch-
pump off. “If the profile is closer 
to the body, it might reduce that.” 
Other participants felt that body 
placement and body type would 
need to be considered, in regard 
to the curve’s effectiveness. P4 
commented “For people who use it 
on their arms and stuff, that curve 
would definitely be more appealing. 
Stomach, you could go either way, 
really.” P5 also mentioned that the 
curve’s effectiveness would depend 
on body type. “I definitely think 
there’s a lot of potential there…I’m 
wondering if it would vary, based 
on body composition/body type.” P6 
expressed indifference, saying her 
patch pump’s footprint is so small, 
she often forgets she’s wearing one. 
The volume of the pump design is 
slightly larger than the current 
Omnipod. While P1 didn’t have 
conclusive feedback for the potential 
effectiveness of the curve, her 
assessment of the design’s wear-
ability was that it may be more likely 
to knock off due to its larger size. 
Recounting her experience using a 
patch pump, P1 stated “I just found 
it annoying to have it on my arm, 
because I would hit it on more things. 
That’s the major issue with this pump, 
is that it’s just a bigger device.”
Examining the 
Refill Process
While all participants found the 
refill feature to be a potentially 
valuable benefit, several drawbacks 
were foreseen. Participants were 
asked to infer whether this would 
be a simple or overly complex task, 
compared the process of refilling 
their own pumps. P2 and P3 felt the 
rubber access flap may be a potential 
weakness. P3 stated, “the rubber tab. 
People without fingernails might find 
it hard to pull.” P3 asked, “With the 
lifting that up and down constantly, 
would there be any issues that you 
could foresee where it could break off 
potentially?” P1 also felt the refilling 
process may be more complicated 
when compared to that of other 
patch-pumps. “The biggest thing I 
liked about the Omnipod is that it 
was the all in one. You could just 
smack it on your arm, or on your 
stomach, and there weren’t extra 
pieces for it…I think the less steps in 
the (refill) process, the easier it will 
be for people.” On the other hand, 
P4-7, felt the refilling process could 
be very simple. P5 stated, “It seems 
super straight forward. You just fill 
up the vial, stick it in, and attach it 
back to the base site.”  P4 mentioned, 
“It’s just automatically appealing to 
me because you don’t have to change 
a pump site. The refilling thing is a 
lot more convenient.”












Assesments of the curved design.
Rating: Simple Somewhat Simple No More Complex 











Assessments of the refilling process
inconclusive inconclusive inconclusiveinconclusiveinconclusive
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Evaluating the Watch 
Controller Form
The controller was presented, 
showing the primary functions 
of the buttons. Lifestyle images 
of the controller being worn on 
the left and right hand were also 
shown. All participants thought the 
arrangement of the buttons and 
trackpad would be easy to interact 
with. P7 mentioned, “Yeah, I think it 
would be really easy to use. And it’s 
kind of like the apple watch, where 
you can use it on either hand. Easy 
to look at and get to.” In evaluating 
the button layout of the controller, P3 
stated, “I like how you explained that 
the selection button is closer to you 
and that makes sense. The interface 
is something that is very simple, but 
to the point that people would be 
able to grasp it fairly easily.”
Participants also gave positive 
feedback in expressing their 
general thoughts on the controller.         
P3 remarked, “I definitely like a 
watch style option. That would be 
very useful. Especially trying to 
wear a dress, or different clothing 
options that you’re wearing, it’s very 
hard sometimes with a pump.” P2, 
and P6 also felt it would potentially 
reduce the number of devices T1D 
people need to carry around, as P2 
mentioned, “Love the watch concept! 
My daughter carries a fanny pack 
with her monitor, extra Omnipod, 
and supplies, and the Omnipod 
controller is too big to fit.” P6 stated, 
“That makes it easier to carry around. 
Right now, I have to carry a purse 
that has my PDM in it.” The watch 
controller was seen as a potentially 
convenient device for busy life 
situations. P3 mentioned, “I think of 
myself as a teacher, when I’m in the 
classroom and I’m working with a 
group of kids and my phone’s over at 
my desk. I’m not running back and 
forth grabbing my phone to check 
my blood sugar data. If I have it right 
there, that’s gonna alert me quickly if 
I have a problem.” P7 also thought the 
design might be useful for younger 
users, “Especially for little ones who 
would use this, I think that’s a great 
idea. Because, then they can keep it 
on them and not set the controller 
down accidentally and then walk 
away and lose it.”
Participants perceeved two potential 
drawbacks of the controller design, 
relating to user preference and 
safety. P1 felt personal preference 
could be a factor, stating, “If you were 
to have it as a device that’s separate 
from the apple watch, you might get 
pushback from people wanting to 
buy it because they would then have 2 
watches. If it doesn’t integrate with a 
watch that they already have.” People 
using a smartwatch would have to 
trade the app capabilities of their 
current system for a model that only 
tells time and controls their APS, 
unless they want to wear two watches. 
In regard to personal preference, 
P5 thought the market saturation 
of smartwatches could be a positive 
sign for the controller, “I think it 
would be very convenient. Especially 
because most people have some sort 
of smartwatch.”   
P7 brougth up a safety factor worth 
considering, “kids might accidentally 
push it. Especially if the buttons are 
protruding. I know, when I had the 
animas pump, I would hit it against 
things and suspend myself.” While 
track pad
Swiping the trackpad activates  the  
  main menu, from the main screen.
Swipe on the track pad for 
scrolling through menus, 
and adding or subtracting      
     numbered items.  
Selection Button
Located on the lower part of the 
controller. Press the selection 
button, to make selections.
Back Button
Press the back button go 
back one step.  The back 
button is Located above 
the selection button. 
Watch Controller Button Functions
Worn on the left hand
Worn on the right hand
Contextual Images
the interactive design strategy aims 
to reduce the risk of accidentally 
suspending or giving abolus, the 
controller should be tested as a 
physical model in order to assess any 
risk factors related to the physical 
buttons.
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Phase 2: Testing the 
Interactive Prototype
Participants were given a hyperlink to 
the web-based interactive prototype, 
before each test began. Since links 
were sent no more than a few hours 
before each session, most participants 
were viewing the prototype for the 
first time.  Prototype functions that 
were tested include evaluation of the 
CGM interface, programming a bolus, 
Suspending the pump, and evaluating 
the quick access features.
Evaluating the 
CGM Scenarios:
The interface’s CGM indicator 
contains several elements that 
communicate glucose levels. Elements 
include the numerical readout, which 
gives the exact glucose number, and 
the arrow indicator which moves up 
or down and changes color, based on 
glucose levels. The arrow indicator 
also points up or down, based on 
glucose trajectory. The first task was 
to evaluate five different scenarios 
depicting different glucose levels on 
the prototype’s CGM indicator. The 
figure below shows each of those 
scenarios.
Participants were asked to evaluate 
the CGM and explain what they think 
the interface is communicating. 
All users were able to interpret the 
numerical readout, immediately. 
Participants were also able to explain 
arrow location and color as graphical 
indicators of glucose levels. As P3 
stated, “If you’re just glancing down 
at your wrist, the color would jump 
out at you first. Especially once you’re 
used to wearing it. And that would 
give you a quick, “yeah I’m good” or, 
‘wait. Maybe I need to look at this 
closer, because maybe I’m in the high 
or low range.’” While all participants 
also successfully interpreted the up, 
down, and horizontal position of 
the arrow as visual indicators, arrow 
orientation tended to be the last 
thing to get noticed. P7 expressed 
that the direction where the arrow 
points to be a less obvious aspect of 
the interface design, “I know, like, 
the red arrow was in a straight line. 
And the green arrow was in a straight 
line. Now the yellow arrow is pointing 
up. Does that mean your blood 
sugar’s going up?” Arrow orientation 
may be an aspect of the interface’s 
visual design that needs further 
consideration.
Steady - On Target Steady - Low Rising - High Decreasing - Low Steady - High




The task of giving a meal bolus was 
subdivided into two sections. While 
bolusing is one of the most common 
interactions to perform on a pump 
this was the most involved task, 
requiring 6 steps and simple addition 
to complete. For the first section, 
participants needed to navigate to 
the bolus landing screen from the 
home screen. For the second half, 
they needed to calculate and deliver 
a meal bolus of 15 carbohydrates. 
This task was evaluated by measuring 
task completion, and number 
of errors that were made.  4 of 7 
participants were able to complete 
the bolus, without instruction. Most 
participants gave notice when they 
saw that the interface was showing 
a “delivering bolus” status.  It is 
thought that P4 completed the bolus 
section and moved on to the home 
screen but was the only participant 
not to communicate task completion 
of the bolus.
Only two errors were communicated 
while in the bolus section. P3 
accidentally selected the suspend 
menu item and suspended insulin 
delivery. She was quickly able to 
resume delivery and go back to the 
bolus section, without instruction. 
P6 had difficulty using the trackpad. 
After some trial and error, she 
enlisted her husband for all trackpad 
interactions, except for adding 
carbohydrates. When adjusting 
carbohydrates, she may have held on 
the lower portion of the trackpad, 
which resulted in a bolus of -36 
carbohydrates. This could have been 
attributed to technical difficulties. 
Since the prototype completely 
malfunctioned on P6’s smartphone, 
it was decided to test the interface 
on her desktop computer. The 
swipe interaction on a smartphone, 
then becomes a mouse click and 
drag action and may have been a 
confusing transition to make from 
smartphone to desktop. Once past the 
trackpad interactions, P6 was able 
to navigate the rest of the interface, 
only needing one instruction to tap 
the selection button for completing 
the bolus user flow.
The prototype has an additional 
feature, where the user can click 
on the selection button while the 
interface is on the delivering insulin 
screen. Doing so takes the interface 
back to the home screen, where an 
additional element gives the status of 
the bolus being delivered. This is not 
a necessary step in delivering a bolus 
and wasn’t counted as a step for 
completing the task. However, P1 was 
able to complete the entire bolus user 
flow and go back to the home screen 
with bolus status element. On finding 
the home screen, P1 stated, “Oh, 
that’s nice. So, you can go back to the 




Suspending then resuming insulin 
delivery was also subdivided into 
two tasks, however all participants 
performed this section with 
confidence. The only error that 
occurred was with P6, who enlisted 
her husband to use the trackpad 
for scrolling on two occasions. After 
completing this task, P1 stated, “That 
was easy. I think as long as it is that 
easy, that’s great.” In commenting 
on the suspend/resume functions, 
P7 stated, “I like how easy it is to 
navigate. Like, there are not a lot of 
options. It’s pretty straight forward.”
Potential Risks detected 
in Bolus and Suspend
Several participants pointed out 
potential risks relating to the 
suspend and bolus sections. There 
were several comments inquiring 
about a lock feature, or better 
safeguard from accidental changes in 
insulin delivery. P1 described a recent 
incident where she accidentally gave 
herself a bolus while asleep, resulting 
in a dangerous low glucose,” I don’t 
remember giving myself insulin 
at all. On the Medtronic there is 
a lock function…but apparently, I 
got through that and gave myself 
insulin… and I didn’t remember 
anything until I woke up in the 
ambulance.” P7 also mentioned the 
physical buttons of the controller as 
something to consider for accidental 
interactions. “The only thing is kids 
might accidentally push it. Especially 
if the buttons are protruding. I know, 
when I had the animas pump, I would 
hit it against things and suspend 
myself.” In discussing the subject 
of suspending vs. programming a 
temporary rate, P6 recounted her 
experiences as a diabetes educator: 
“In training patients, I never taught 
them to suspend. Always use a 
temporary basal, because I just think 
it’s too common for people to forget 
to start it back up. And then you 
get higher, or you go into DKA.” P5 
also noted the importance of having 
consistent alerts for when the pump 
is suspended. With the prototype user 
flow, the suspend option shows up 
before the temporary basal rate. For 
future iterations, a safer user flow 
may be to give users the option to 
perform a temporary basal, before 
they get to the suspend option. It 
may also be worth exploring other 
functions to replace suspend as a 
quick access feature.











P1 C C C C C C C C
P2 I I I I C C C
P3 C C I C, E C C C
P4 I C I C X X X
P5 C C C C C C C
P6 C C I C, E I C C
P7 C C C C C C C
Key:







The interface’s quick access features 
(CGM detail view and quick suspend) 
were tested for perceived usefulness 
and acceptance. The features are 
somewhat hidden in the interface 
design as Easter eggs. They aren’t 
accessible through the navigation 
menu. Instead, they are activated by 
pressing and holding on either the 
back button or select button for two 
seconds. Due to the concealed nature 
of these features, participants were 
simply told to press and hold either 
of the buttons and interpret what 
they see. 
In accessing the quick suspend 
feature, P1 stated, “If you’re going low 
and you need to suspend, it makes 
sense to have that.” P3 described the 
interaction for the quick suspend 
feature, “I like how you have to hold 
(the button down), so you’re not 
going to accidentally get yourself into 
a situation where you’ve suspended 
your insulin.”  P6 discussed the 
safety factors that could go into 
suspending delivery, “There’s nothing 
wrong with suspending, as long as 
you’ve got an alarm that’s going 
to let you know...’You’ve turned me 
off, and now you’re 200!’” While the 
interface prototype features haptic 
responses for suspend, and several 
other interactions, the variation in 
how each participant setup their 
smartphone was too wide to be able 
to reliably test haptics. P3 was able to 
follow all necessary steps in order to 
get haptic responses working for the 
prototype. She only perceived one of 
about 6 prototype interactions that 
give a vibration response. 
The CGM detail view graph was the 
second quick access feature to be 
tested. Many participants noted 
that having a CGM detail history is 
an integral feature. P2 stated, “The 
graph is something I would use 
frequently. I bolus based on graph 
trends.” P6 also stated, “I like to 
look at that. I kind of like to look for 
where I came from and where I’m at.” 
From a purely aesthetic perspective, 
P7 stated, “Ooh! That looks better 
than my graph!” Several participants 
asked if the high and low threshold 
points of the graph could be set to 
the user’s preference, as in other 
popular closed loop systems.
The original aim of this study was 
to design an insulin pump interface 
that allows for enhanced discreet 
and eyes-free operation, in order 
to reduce feelings of insecurity 
and interruptions among pump 
users. Adopting a user-centered 
investigative methodology, we found 
that many people experience feelings 
of insecurity and inconvenience 
while using pumps in public 
settings or performing demanding 
tasks. We uncovered several other 
significant issues, including wear-
ability challenges that limit pump 
and clothing options for women, 
and pain points in keeping track 
of multiple devices which must be 
carried at all times. Participants 
expressed hardships, bumping into 
objects and pulling the pump tubing 
out, or dislodging the entire patch 
pump. Lastly, we found shortcomings 
in pump interface designs. People 
mentioned having to take an 
excessive number of steps in order 
to complete tasks, and frustration 
in dealing with alerts. Some users 
also found informational screens, 
like the bolus history, difficult to 
interpret. Taking all of these insights 
into account, we were able to design 
relevant potential solutions.
The usability testing insights 
indicated that this insulin pump 
concept shows potential as a 
refillable patch pump. Further 
testing needs to be done in order to 
reveal the effectiveness of the curved 
design for enhanced wear-ability 
and reduced dislodging, however 
study participants welcomed the 
idea of a patch pump that offers 
refilling capabilities. While several 
participants found that the refilling 
process could be simplified to 
make the design more appealing, 
the overall pump design was well 
recieved.  P6 stated, “With all you’ve 
got now, it looks like a great concept. 
You might hook up with another 
company that could help you to 
fruition”. Several other participants 
requested to stay in contact 
regarding further developments with 
the pump and controller concept.
Participants showed acceptance 
of the watch controller as a highly 
wearable device, imagining it would 
reduce the number of devices one 
must carry around. It was also 
viewed as a convenient option for 
interaction, since it is primarily 
worn on the hand and not stored 
in a pocket or purse, making it 
readily accessible. Even though the 
controller design is a novel concept 
for a pump interface, participants 
felt it would be acceptable to wear, 
given the current market saturation 
of smartwatches. 
The interactive design strategy 
helped to ensure that the pump 
interface remained consistent 
throughout the whole user 
experience. This was one of the 
factors that lead to a more successful 
set of usability tests. Participants 
performed most interface tasks 
quickly and without making 
mistakes. After using the unique 
trackpad feature once or twice, 
all but one participant became 
proficient in using it for scrolling 
menus and adjusting numbered 
items. Many participants were vocal 
that the interface was simple to 
navigate and gave favorable reviews 
of the quick access features. The 
interface wasn’t without issues, 
though. The CGM was less effective at 
communicating glucose trajectory, by 
changing orientation. The interface 
should also be reassessed for risk 
factors, such as accidentally giving 
a bolus or suspending the pump. 
Testing the current haptic feedback 
interactions of the interface may 
also lead to valuable insight, once 
in-person usability sessions become 
a viable method. It was originally 
hoped that haptic features would 
prove effective at allowing discreet 
eyes-free interaction. Unfortunately, 
it was nearly impossible to test 
haptic features reliably, during the 
remote sessions. While the current 
prototype features several haptic 
interactions, participant 3 was the 
only person able to activate vibration 
on her device, which only gave haptic 
feedback once. There is also room 
for design exploration on a safety 
lock feature which would disable 
the interface, to prevent accidental 
interactions. 
In working with people during 
multiple phases of the design 
process, it was apparent that there 
are gaps between an ideal pump 
experience, and the experiences that 
many current technologies offer. A 
user-centered approach, such as the 
one used in this study, could help to 
bridge that gap. I personally found 
that the interface’s CGM design could 
have been improved if I had reviewed 
early sketches with pump users, 
before moving into the higher fidelity 
designs. While this oversight led to a 
design flaw, it points to the benefits 
of incorporating users in the design 
process. The hope of this project is 
to help convey the importance of 
incorporating the input from people 
who depend on insulin pumps. 
Building on the current industry’s 
user-centered approaches may lead 
to valuable innovations in diabetes 
management technologies. 
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